Health-Related Quality of Life in Young Adults Following Pediatric Arterial Ischemic Stroke.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 24 12 2019
medline: 23 6 2020
entrez: 24 12 2019
Statut: ppublish

Résumé

Background and Purpose- Pediatric arterial ischemic stroke (AIS) is a rare disease leading to long-lasting neurological sequelae. Little is known about the long-term health-related quality of life (HRQoL) of these patients. The study aims to compare HRQoL in young adults who have had pediatric AIS with a healthy control group. Methods- A cross-sectional study compared self-rated HRQoL, depression, fatigability, and behavior in pediatric stroke survivors to healthy controls. Patients with a confirmed diagnosis of pediatric AIS who were ≥18 years at the time of recruitment and ≥2 years after acute AIS, as well as healthy controls ≥18 years matched for age, sex, and socioeconomic status were included. Primary outcome was HRQoL measured with the Short Form Health Survey. Results- Thirty-three patients (median [interquartile range] aged 22 years [20-26]; 22 males, 67%) and 71 controls (median [interquartile range] aged 23 years [21-25]; 41 males, 58%) were included. Overall, HRQoL, depression, or fatigability did not differ between the patients and the control group. Patients rated themselves lower on the disinhibition scale (

Identifiants

pubmed: 31865895
doi: 10.1161/STROKEAHA.119.027622
doi:

Types de publication

Clinical Trial Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

952-957

Commentaires et corrections

Type : CommentIn

Auteurs

Aline Rohner (A)

From the Division of Child Neurology, Department of Pediatrics, University Children's Hospital Bern, Bern University Hospital, and University of Bern, Switzerland on behalf of the Swiss Neuropaediatric Stroke Registry (A.R., B.K., K.L., M.R., M.S., S.B.).

Klemens Gutbrod (K)

Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Switzerland (K.G., U.F., B.G.-S.).

Barbara Kohler (B)

From the Division of Child Neurology, Department of Pediatrics, University Children's Hospital Bern, Bern University Hospital, and University of Bern, Switzerland on behalf of the Swiss Neuropaediatric Stroke Registry (A.R., B.K., K.L., M.R., M.S., S.B.).

Karen Lidzba (K)

From the Division of Child Neurology, Department of Pediatrics, University Children's Hospital Bern, Bern University Hospital, and University of Bern, Switzerland on behalf of the Swiss Neuropaediatric Stroke Registry (A.R., B.K., K.L., M.R., M.S., S.B.).

Urs Fischer (U)

Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Switzerland (K.G., U.F., B.G.-S.).

Barbara Goeggel-Simonetti (B)

Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Switzerland (K.G., U.F., B.G.-S.).
Division of Child Neurology, Istituto Pediatrico della Svizzera Italiana, Bellinzona, Switzerland (B.G.-S.).

Maria Regenyi (M)

From the Division of Child Neurology, Department of Pediatrics, University Children's Hospital Bern, Bern University Hospital, and University of Bern, Switzerland on behalf of the Swiss Neuropaediatric Stroke Registry (A.R., B.K., K.L., M.R., M.S., S.B.).

Maja Steinlin (M)

From the Division of Child Neurology, Department of Pediatrics, University Children's Hospital Bern, Bern University Hospital, and University of Bern, Switzerland on behalf of the Swiss Neuropaediatric Stroke Registry (A.R., B.K., K.L., M.R., M.S., S.B.).

Sandra Bigi (S)

From the Division of Child Neurology, Department of Pediatrics, University Children's Hospital Bern, Bern University Hospital, and University of Bern, Switzerland on behalf of the Swiss Neuropaediatric Stroke Registry (A.R., B.K., K.L., M.R., M.S., S.B.).
Swiss Epilepsy Clinic, Klinik Lengg, Zürich, Switzerland (S.B.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH